GSK2202083A vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2202083A vaccine, covering 2017-04-04 to 2017-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]